New research finds that psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.
Read more5-MeO-DMT Research
This research reviews the available literature about 5-MeO-DMT and informs subsequent clinical development.
Read morePsilocybin-assisted Therapy
From Johns Hopkins Psychedelic Newsletter Fall 2021:
Last year, Dr. Frederick Barrett published a study that showed psilocybin reduced neural activity in the claustrum during the period of drug action.
The claustrum, once thought to be the seat of consciousness, is a thin sheet of gray matter in the brain that reaches out to every other region in the brain.
The results showed that both the default mode network and areas of the brain believed to be responsible for setting attention and switching tasks may be disrupted during the effects of psilocybin, and alterations in the claustrum may account for these changes.
Read morePsychedelic Utopia is a Myth
Some advocates claim that widespread psychedelic use will change the world for the better. But it’s not so simple.
Read moreLargest Psilocybin Trial
The largest psilocybin trial to date finds the psychedelic is effective in treating serious depression.
Eagerly awaited results of the largest-ever study of psilocybin were announced Tuesday, with Compass Pathways revealing the psychedelic drug was highly efficacious as a therapy for treatment-resistant depression.
Read moreBook Review: This is Your Mind on Plants, by Michael Pollan
Michael Pollan plunges into mescaline, opium, and caffeine in his new book.
Read morePsilocybin, Depression and Cancer
COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients.
Within one week of a single administration of COMP360 psilocybin therapy, 50% of participants achieved remission in depression symptoms, which was sustained for the eight week follow-up period.
Read moreMore Research Coming!
Well this is exciting: The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.
Read moreThe Role of Drugs in Society
https://www.youtube.com/watch?v=3LWNY70Oj4A
Carl Hart is a psychologist at Columbia University. Here he talks about heroin, cocaine, MDMA, alcohol & the role of drugs in society.
Read moreInterview with Rick Doblin
Keep reading for an interview with pioneering psychedelic activist Rick Doblin about the promise of MDMA therapy for PTSD, working with Republicans, and his hope for a drug-assisted global spiritual awakening.
Read moreThe Masks We Wear
The disguises we wear every day… Hiding your feelings can be freeing. But eventually you have to take off the mask.
Read more